CVE Intelligence
Medium Cross-site scripting exploit reference

CVE-2025-65215 — Cross-site Scripting (XSS) in Senior-walter Web-based Pharmacy Product Management System

Sourcecodester Web-based Pharmacy Product Management System v1.0 is vulnerable to Cross Site Scripting (XSS) in /product_expiry/add-supplier.php via the Supplier Name field.

Published Dec 2, 2025 · Updated Oct 13, 2026 · Sources: NIST National Vulnerability Database, CVE Program (cve.org) e CISA ADP · CNA: mitre

Who exploits it and how urgent it is

A 0–100 score combining confirmed exploitation, ransomware and APT use, public exploits, EPSS and severity.

No exploitation signal in the sources consulted so far.
How the score was calculated
  • EPSS 0.2% (30-day exploitation probability)+2
  • Technical severity (medium)+3
  • CISA SSVC: exploitation "poc"+5

The score orders the patch queue; it does not replace your asset context (internet exposure, criticality, compensating controls).

Triage

Is it exploited, how likely is exploitation, what does it touch, and how severe do the sources call it.

Exploitation
Not confirmed
Not in CISA KEV — an absence of record, not proof it is unexploited.
EPSS FIRST
0.23%
ahead of 12% of scored CVEs · Oct 14, 2026
Affects
Senior-walter
Web-based Pharmacy Product Management System
CVSS base
6.1
Medium · 2 source(s)

CISA SSVC assessment CISA

Three decision points CISA publishes for the CVEs it assesses (SSVC 2.0.3). A stakeholder decision, not a severity score.

Exploitation
Proof of concept
none · proof-of-concept · active
Automatable
No
can an attacker script the kill-chain steps
Technical impact
Partial
partial · total control of the vulnerable component

Remediation

Fixes and mitigations documented by the sources — linked to the original advisory.

No fix documented by the sources we poll. That does not mean none exists: check the vendor advisory.

First 24 hours

Ordered from the record’s own fields — exposure first, because you cannot patch what you have not found. A rule-generated starting point.

  1. Identify exposed assets running the affected vendor/product/version combinations (Senior-walter Web-based Pharmacy Product Management System).
  2. The attack is network-based and needs no privileges: restrict exposure (ACLs, VPN, WAF) until patched.
  3. No fix documented in the sources: reduce exposure and monitor the vendor advisory.
  4. Exploitation requires user interaction: tighten email/web filtering and warn affected users.
  5. Search available logs for exploit probes matching the vulnerability class (cross-site scripting), errors and authentication anomalies.

Affected scope

Vendor, product and versions as the sources word them.

VendorProductVersionsStatusSource
Senior-walter Web-based Pharmacy Product Management System version 1.0 Vulnerable NIST National Vulnerability Database

Attack characteristics

The CVSS vector, decoded. It describes the attack, not your exposure to it.

Attack vector
Network
Attack complexity
Low
Privileges required
None
User interaction
Required
Scope
Changed
Confidentiality
Low
Integrity
Low
Availability
None

Every base score collected

Sources score independently and may disagree; each row says who scored it and under which version.

ScoreVersionSeverityExpl.ImpactScored by
6.1 CVSS 3.1 Medium 2.8 2.7 134c704f-9b21-4f2e-91b3-4a467353bcc0 via NIST National Vulnerability Database
6.1 CVSS 3.1 Medium — — CISA-ADP via CVE Program (cve.org) e CISA ADP
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N (score shown at the top: 134c704f-9b21-4f2e-91b3-4a467353bcc0)

Weakness MITRE

Weakness class according to MITRE’s CWE catalog.

CWE-79 · Cross-site Scripting (XSS)

Other CVEs with this weakness →

EPSS over time FIRST

Oct 13, 2026 → Oct 14, 2026 · 2 reading(s) · max 0.23%

Detection

Read off the CVSS vector and the weakness class. Starting points, not tested rules.

  • Prioritize edge telemetry for the network-reachable component (proxy, WAF, IDS/IPS).
  • Monitor CSP violation reports and script payloads in reflected parameters.
web/proxy/WAF logsnetwork IDS/IPSapplication logs

Timeline

What happened to this CVE, newest first.

  • 2026
  • SSVC assessment updated
    Oct 13, 2026 · CVE Program (cve.org) e CISA ADP
  • Record published
    Oct 13, 2026
  • CVSS changed · 6.1
    Oct 13, 2026 · NIST National Vulnerability Database
  • Source status changed · → Analyzed
    Oct 13, 2026 · NIST National Vulnerability Database
  • Record created in this database
    Oct 13, 2026 · NIST National Vulnerability Database
  • 2025
  • CVE published
    Dec 2, 2025 · mitre

Source activity

Repeated readings are counted rather than listed.

  • 1× Official description updated · Oct 13, 2026 – Oct 13, 2026

References

2 on the record

Elsewhere on this site

Senior-walter
every CVE for this vendor
Cross-site scripting
same class
CWE-79
other pages naming this weakness

Related CVEs (same products)

  • CVE-2026-30573 A Business Logic vulnerability exists in SourceCodester Pharmacy Product Management… Apr 1, 2026
  • CVE-2026-30576 Improper Input Validation in Senior-walter Web-based Pharmacy Product Management System Mar 27, 2026
  • CVE-2026-30574 A Business Logic vulnerability exists in SourceCodester Pharmacy Product Management… Mar 27, 2026
  • CVE-2026-30575 Improper Input Validation in Senior-walter Web-based Pharmacy Product Management System Mar 27, 2026
  • CVE-2026-3766 SourceCodester Web-based Pharmacy Product Management System edit-profile.php cross site scripting Mar 8, 2026
  • CVE-2026-3401 SourceCodester Web-based Pharmacy Product Management System session expiration Mar 1, 2026

Not in any source we poll

Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.

  • No fixed version, patch or mitigation documented.
  • No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
  • No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
  • No exploit packet captures, log samples, or incident case IDs supplied.

Answered from this record

Text assembled only from the fields above — no additional claims.

What should defenders know first?

CVE-2025-65215 is "Cross-site Scripting (XSS) in Senior-walter Web-based Pharmacy Product Management System", rated Medium. It affects Web-based Pharmacy Product Management System (Senior-walter); versions are in the scope table. It is not in CISA KEV, which does not rule out exploitation. CVSS 6.1 describes technical severity. EPSS 0.23% estimates the probability of exploitation in 30 days; neither replaces your asset context. First verify whether exposed or business-critical assets run the affected versions, apply vendor fixes or mitigations, and preserve logs for review.

Comments

Moderated technical discussion. Read the community guidelines.

No comments yet.

Sign in or create an account to comment and suggest corrections.